ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,210.57
0.38%
Dow Jones
39,164.06
0.09%
Gold vs US Dollar
2,328.36
0.02%
Brent Oil
86.085
0.78%
Bitcoin
61,333.01
-0.45%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. Viking Therapeutics Inc (VKTX) Share Price

VKTX Viking Therapeutics Inc

51.29
0.52 (1.02%)
Pre Market
Last Updated: 10:09:43
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 Viking Therapeutics Inc NASDAQ:VKTX NASDAQ Common Stock  
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.52 1.02 51.29 51.11 51.50 0.00 0.00  1,498 09:09:43   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations  -85.9M -0.7790 -65.17 5.6B
 Type  Size  Price  Time  Units 
 9 46 51.30 09:09:43 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore VKTX News
24/06/202412:33PRNUSViking Therapeutics Presents Preclinical Data on Novel Dual Amylin and Calcitonin Receptor Agonists at 84th Scientific Sessions of the American Diabetes Association
04/06/202412:10EDGAR2Form 8-K - Current report
04/06/202412:05PRNUSViking Therapeutics Announces Positive 52-Week Histologic Data from Phase 2b VOYAGE Study of VK2809 in Patients with Biopsy-Confirmed Non-Alcoholic Steatohepatitis (NASH)
30/05/202421:03PRNUSViking Therapeutics to Participate at Upcoming Investor Conferences
22/05/202422:12EDGAR2Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
22/05/202421:33EDGAR2Form S-8 - Securities to be offered to employees in employee benefit plans
24/04/202421:05PRNUSViking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Period
Draw mode
Data Downloads for VKTX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest Viking Therapeutics Inc Articles